Coverage by line
Premium dollars by benefit type (bundled lines overlap)
- Long-term disability$25K
- Other$8K
Sponsor portfolio
GALEPHAR PHARMACEUTICAL RESEARCH, INC.
EIN 66-0565645Latest filing 2025
Plans
3
Retirement
1
$464K assets
Welfare
2
$33K premiums
Participants
436
HC 4 BOX 4540 - HUMACAO, PR 007918934787-389-0340
Plans on this EIN
3 filingsBenefits portfolio analytics
2 plans / $33K premiums / 171 covered livesCarrier market share
Premium dollars by Schedule A carrier
100%top
- TRIPLE S SALUD, INC.100%
Broker market share
Schedule A broker compensation
50%top
- IKON INSURANCE, INC.50%
- ACRISURE LLC50%
Plan deep-dives
Per-plan teasers. The full analytics (fees vs peers, audit grade, trajectory, counterparties) live on each plan detail page.Retirement#001
GALEPHAR PHARMACEUTICAL RETIREMENT PLAN
401k
Assets$464K
Participants123
Inside the deep dive
Fees vs peersAudit gradeAsset trajectoryContributionsSch C providers
Open plan deep dive
Welfare#502
GALEPHAR PHARMACEUTICAL RESEARCH, INC- LTD PLAN
Fully Insured - TRIPLE S VIDA
Premiums$25K
Covered lives15
Inside the deep dive
Premium breakdownCarriersBrokersCoverage stats
Open plan deep dive
Welfare#503
GALEPHAR PHARMACEUTICALS RESEARCH, INC.- CANCER POLICY
Fully Insured - TRIPLE S VIDA
Premiums$8K
Covered lives156
Inside the deep dive
Premium breakdownCarriersBrokersCoverage stats
Open plan deep dive
Retirement plans1
| Plan # | Name | Type | Assets | Participants | Latest year | |
|---|---|---|---|---|---|---|
| 001 | GALEPHAR PHARMACEUTICAL RETIREMENT PLAN | 401k | $464K | 123 | 2024 |
Welfare plans2
| Plan # | Name | Funding | Carrier | Premiums | Covered | Latest year | |
|---|---|---|---|---|---|---|---|
| 502 | GALEPHAR PHARMACEUTICAL RESEARCH, INC- LTD PLAN | Fully Insured | TRIPLE S VIDA | $25K | 15 | 2025 | |
| 503 | GALEPHAR PHARMACEUTICALS RESEARCH, INC.- CANCER POLICY | Fully Insured | TRIPLE S VIDA | $8K | 156 | 2025 |
Retirement plans
Welfare plans